These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8611028

  • 1. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts.
    Xu XQ, McGuire TF, Blaskovich MA, Sebti SM, Romero G.
    Arch Biochem Biophys; 1996 Feb 15; 326(2):233-7. PubMed ID: 8611028
    [Abstract] [Full Text] [Related]

  • 2. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM.
    J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul 15; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 4. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity.
    McGuire TF, Xu XQ, Corey SJ, Romero GG, Sebti SM.
    Biochem Biophys Res Commun; 1994 Oct 14; 204(1):399-406. PubMed ID: 7524501
    [Abstract] [Full Text] [Related]

  • 5. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP, Buckley DJ, Buckley AR.
    Cell Growth Differ; 1995 Oct 14; 6(10):1235-44. PubMed ID: 8845300
    [Abstract] [Full Text] [Related]

  • 6. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F, Bonnec G, Tardivel A, Boujard D.
    Dev Biol; 1997 Aug 01; 188(1):122-33. PubMed ID: 9245517
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I).
    Hansson A, Hehenberger K, Thorén M.
    Cell Biochem Funct; 1996 Jun 01; 14(2):121-9. PubMed ID: 8640952
    [Abstract] [Full Text] [Related]

  • 9. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
    Sorokin A, Reed E, Nnkemere N, Dulin NO, Schlessinger J.
    Oncogene; 1998 May 14; 16(19):2425-34. PubMed ID: 9627109
    [Abstract] [Full Text] [Related]

  • 10. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase.
    Hu ZW, Shi XY, Lin RZ, Chen J, Hoffman BB.
    J Pharmacol Exp Ther; 1999 Jul 14; 290(1):28-37. PubMed ID: 10381756
    [Abstract] [Full Text] [Related]

  • 11. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY, Kim BC, Lee HS.
    Transl Res; 2008 Jan 14; 151(1):27-35. PubMed ID: 18061125
    [Abstract] [Full Text] [Related]

  • 12. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
    Kranenburg O, Verlaan I, Hordijk PL, Moolenaar WH.
    EMBO J; 1997 Jun 02; 16(11):3097-105. PubMed ID: 9214627
    [Abstract] [Full Text] [Related]

  • 13. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils.
    Bates ME, Bertics PJ, Busse WW.
    J Immunol; 1996 Jan 15; 156(2):711-8. PubMed ID: 8543824
    [Abstract] [Full Text] [Related]

  • 14. cAMP inhibits the insulin-stimulated mitogen-activated protein kinase pathway in rat hepatoma H4EII cells.
    Nagasaka Y, Kaku K, Nakamura K, Kaneko T.
    Biochem Biophys Res Commun; 1994 Jul 29; 202(2):1104-12. PubMed ID: 8048924
    [Abstract] [Full Text] [Related]

  • 15. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
    Zanella CL, Posada J, Tritton TR, Mossman BT.
    Cancer Res; 1996 Dec 01; 56(23):5334-8. PubMed ID: 8968079
    [Abstract] [Full Text] [Related]

  • 16. Effects of an antiallergic drug, pemirolast potassium on tyrosine phosphorylation and map kinase activation in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells.
    Nakamura Y, Nakashima S, Fujimiya H, Kumada T, Kato Y, Miyata H, Nozawa Y.
    Arerugi; 1995 Jan 01; 44(1):34-44. PubMed ID: 7702453
    [Abstract] [Full Text] [Related]

  • 17. Distinct protein tyrosine phosphorylation during mitogenesis induced in quiescent SV40-transformed 3T3 T cells by insulin or vanadate.
    Wang H, Scott RE.
    J Cell Physiol; 1994 Mar 01; 158(3):408-16. PubMed ID: 8126065
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.